Insider Transactions in Q2 2023 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,104
-3.42%
|
$35,520
$5.9 P/Share
|
|
Jun 30
2023
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,419
-3.64%
|
$52,095
$5.9 P/Share
|
|
Jun 30
2023
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
6,419
-4.09%
|
$32,095
$5.9 P/Share
|
|
Jun 30
2023
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,290
-0.44%
|
$21,450
$5.9 P/Share
|
|
Jun 30
2023
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,263
-4.05%
|
$181,315
$5.9 P/Share
|
|
Jun 30
2023
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,742
-4.02%
|
$58,710
$5.9 P/Share
|
|
Jun 01
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
6,500
-0.82%
|
$26,000
$4.45 P/Share
|
|
May 24
2023
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Indirect |
8,000
-81.25%
|
$32,000
$4.49 P/Share
|
|
May 01
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
6,800
-0.85%
|
$27,200
$4.42 P/Share
|
|
Apr 03
2023
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
6,700
-0.83%
|
$20,100
$3.69 P/Share
|